Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents
Clinical trial NCT04992260 · COMPLETED
Trial details
- NCT number
- NCT04992260
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2023-05-31
- Enrollment
- 11349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.